Zymeworks (ZYME) Assets Average (2022 - 2026)
Zymeworks recorded quarterly Assets Average of $412.4 million in Q1 2026, up 10.88% quarter-over-quarter from $371.9 million in Q4 2025, and down 7.19% year-over-year from $444.3 million in Q1 2025.
Zymeworks' Assets Average history runs 5 years deep, the most recent figure standing at $412.4 million for Q1 2026.
- In Q1 2026, Assets Average fell 7.19% year-over-year to $412.4 million; the TTM figure through Mar 2026 stood at $412.4 million (down 7.19% YoY), while the FY2025 annual figure was $404.8 million, down 22.45% from the prior year.
- Assets Average came in at $412.4 million for Q1 2026 at Zymeworks, up from $371.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $624.7 million in Q1 2023 to a low of $371.9 million in Q4 2025.
- A 5-year average of $498.2 million and a median of $488.3 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average advanced 19.84% in 2023 and slipped 22.02% in 2025, its largest moves.
- Zymeworks' Assets Average stood at $474.5 million in 2022, then rose by 19.84% to $568.6 million in 2023, then fell by 16.44% to $475.1 million in 2024, then decreased by 21.73% to $371.9 million in 2025, then gained by 10.88% to $412.4 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $412.4 million, $371.9 million, and $402.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 412.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 412.37 Mn |
| Dec 31, 2025 | 371.90 Mn |
| Sep 30, 2025 | 402.83 Mn |
| Jun 30, 2025 | 416.95 Mn |
| Mar 31, 2025 | 444.31 Mn |
| Dec 31, 2024 | 475.12 Mn |
| Sep 30, 2024 | 501.39 Mn |
| Jun 30, 2024 | 534.69 Mn |
| Mar 31, 2024 | 567.32 Mn |
| Dec 31, 2023 | 568.62 Mn |
| Sep 30, 2023 | 579.21 Mn |
| Jun 30, 2023 | 601.40 Mn |
| Mar 31, 2023 | 624.73 Mn |
| Dec 31, 2022 | 474.49 Mn |